Explore more publications!
Mississippi Healthcare Reporter
Got News to Share?

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 24, 2026

Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work
Apr. 24, 2026

Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work

Indeterminate GlobeNewswire
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr. 24, 2026

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call
Apr. 24, 2026

Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
Apr. 24, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
AEON Biopharma Sets Annual Shareholder Meeting
Apr. 24, 2026

AEON Biopharma Sets Annual Shareholder Meeting

Indeterminate GlobeNewswire
Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026
Apr. 24, 2026

Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026

Indeterminate GlobeNewswire
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
Apr. 24, 2026

Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer

Indeterminate GlobeNewswire
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
Apr. 24, 2026

FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order

Indeterminate GlobeNewswire
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
Apr. 24, 2026

Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim

Indeterminate GlobeNewswire
ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026
Apr. 24, 2026

ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026

Indeterminate GlobeNewswire
Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill
Apr. 24, 2026

Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill

Indeterminate GlobeNewswire
Press Release: Sanofi successfully prices 2.3 billion of bond issue
Apr. 24, 2026

Press Release: Sanofi successfully prices 2.3 billion of bond issue

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires
Apr. 24, 2026

Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires

Indeterminate GlobeNewswire
RTA Outdoor Living Launches 'Health Haven' YouTube Special on Backyard Design and Health
Apr. 24, 2026

RTA Outdoor Living Launches 'Health Haven' YouTube Special on Backyard Design and Health

Indeterminate GlobeNewswire
Metabo Drops 2026 | Launch "Tasteless Drop Effective Weight Loss Turns Any Coffee Into Boosted Metabolism Explained Fat Burning Supplement MetaboDrops
Apr. 24, 2026

Metabo Drops 2026 | Launch "Tasteless Drop Effective Weight Loss Turns Any Coffee Into Boosted Metabolism Explained Fat Burning Supplement MetaboDrops

Indeterminate GlobeNewswire
KFSH Scales Genomic Medicine from Research to Clinical Decision-Making
Apr. 24, 2026

KFSH Scales Genomic Medicine from Research to Clinical Decision-Making

Indeterminate GlobeNewswire
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
Apr. 24, 2026

Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder

Indeterminate GlobeNewswire
DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration
Apr. 24, 2026

DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

Indeterminate GlobeNewswire
Medicana Health Group Launches HPV Vaccination and Cervical Cancer Awareness Campaign, Advancing Prevention Through Regular Check-Ups
Apr. 24, 2026

Medicana Health Group Launches HPV Vaccination and Cervical Cancer Awareness Campaign, Advancing Prevention Through Regular Check-Ups

Indeterminate GlobeNewswire
A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform
Apr. 24, 2026

A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions